Clinical use of high dose methotrexate within the Queensland Radium Institute.
The Royal Brisbane Hospitals Group is the second largest user of methotrexate in Australia. The Queensland Radium Institute and the Royal Children's Hospital are both members of the Royal Brisbane Hospitals Group and they are responsible for high dose methotrexate treatment of adults and children within the Group. Children requiring such treatment are seen by staff from both centres. Therefore, the report which follows describes the usage in both adults and children.
D001315:Australia; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002648:Child; D002813:Chondrosarcoma / Q000188:drug therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy; D012516:Osteosarcoma / Q000188:drug therapy; D010166:Palliative Care; D013724:Teratoma / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy
D008727:Methotrexate